TAPBPR: A new player in the MHC class I presentation pathway

Tissue Antigens

Volumn 85, Issue 3, 2015, Pages 155-166

  Hermann, C ^a,b   Trowsdale, J ^a   Boyle, L H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Antigen processing and presentation; Disease association; Human; Major histocompatibility complex (MHC); Tapasin; TAPBPR TAPBPL

Indexed keywords

AMINOPEPTIDASE; CALNEXIN; CALRETICULIN; CHAPERONE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TAPASIN; TAPASIN RELATED PROTEIN TAPBPR; UDP GLUCOSE GLYCOPROTEIN GLUCOSYLTRANSFERASE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCOSE; CARRIER PROTEIN; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN; MEMBRANE PROTEIN; PEPTIDE; TAPBPL PROTEIN, HUMAN;

ANTIGEN PRESENTATION; CELL CYCLE CHECKPOINT; CELL SURFACE; CROSS PRESENTATION; DENDRITIC CELL; ENDOPLASMIC RETICULUM; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; QUALITY CONTROL; REVIEW; SECRETORY PATHWAY; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANTIGEN PRESENTING CELL; CELL MEMBRANE; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PROTEIN TRANSPORT;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CELL MEMBRANE; ENDOPLASMIC RETICULUM; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOGLOBULINS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 84923376447     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12538     Document Type: Review

References (107)

1. Van Hateren A, James E, Bailey A, Phillips A, Dalchau N, Elliott T. The cell biology of major histocompatibility complex class I assembly: towards a molecular understanding. Tissue Antigens 2010: 76: 259-75.
2. Yewdell JW, Anton LC, Bennink JR. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? J Immunol 1996: 157: 1823-6.
3. Eisenlohr LC, Huang L, Golovina TN. Rethinking peptide supply to MHC class I molecules. Nat Rev Immunol 2007: 7: 403-10.
4. Saunders PM, van Endert P. Running the gauntlet: from peptide generation to antigen presentation by MHC class I. Tissue Antigens 2011: 78: 161-70.
5. Apcher S, Daskalogianni C, Lejeune F et al. Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation. Proc Natl Acad Sci U S A 2011: 108: 11572-7.
6. Apcher S, Millot G, Daskalogianni C, Scherl A, Manoury B, Fahraeus R. Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathway. Proc Natl Acad Sci U S A 2013: 110: 17951-6.
7. Starck SR, Jiang V, Pavon-Eternod M et al. Leucine-tRNA initiates at CUG start codons for protein synthesis and presentation by MHC class I. Science 2012: 336: 1719-23.
8. Deverson EV, Gow IR, Coadwell WJ, Monaco JJ, Butcher GW, Howard JC. MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature 1990: 348: 738-41.
9. Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A. Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters. Nature 1990: 348: 741-4.
10. Spies T, Bresnahan M, Bahram S et al. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 1990: 348: 744-7.
11. Salter RD, Cresswell P. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J 1986: 5: 943-9.
12. Spies T, DeMars R. Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature 1991: 351: 323-4.
13. Spies T, Cerundolo V, Colonna M, Cresswell P, Townsend A, DeMars R. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature 1992: 355: 644-6.
14. Saric T, Chang SC, Hattori A et al. An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat Immunol 2002: 3: 1169-76.
15. Serwold T, Gonzalez F, Kim J, Jacob R, Shastri N. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 2002: 419: 480-3.
16. Evnouchidou I, Weimershaus M, Saveanu L, van Endert P. ERAP1-ERAP2 dimerization increases peptide-trimming efficiency. J Immunol 2014: 193: 901-8.
17. York IA, Chang SC, Saric T et al. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat Immunol 2002: 3: 1177-84.
18. Kanaseki T, Lind KC, Escobar H et al. ERAAP and tapasin independently edit the amino and carboxyl termini of MHC class I peptides. J Immunol 2013: 191: 1547-55.
19. Ellgaard L, Bettendorff P, Braun D et al. NMR structures of 36 and 73-residue fragments of the calreticulin P-domain. J Mol Biol 2002: 322: 773-84.
20. Frickel EM, Riek R, Jelesarov I, Helenius A, Wuthrich K, Ellgaard L. TROSY-NMR reveals interaction between ERp57 and the tip of the calreticulin P-domain. Proc Natl Acad Sci U S A 2002: 99: 1954-9.
21. Leach MR, Cohen-Doyle MF, Thomas DY, Williams DB. Localization of the lectin, ERp57 binding, and polypeptide binding sites of calnexin and calreticulin. J Biol Chem 2002: 277: 29686-97.
22. Zhang Y, Baig E, Williams DB. Functions of ERp57 in the folding and assembly of major histocompatibility complex class I molecules. J Biol Chem 2006: 281: 14622-31.
23. Degen E, Cohen-Doyle MF, Williams DB. Efficient dissociation of the p88 chaperone from major histocompatibility complex class I molecules requires both beta 2-microglobulin and peptide. J Exp Med 1992: 175: 1653-61.
24. Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 1996: 5: 103-14.
25. Park B, Lee S, Kim E et al. Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing. Cell 2006: 127: 369-82.
26. Peaper DR, Wearsch PA, Cresswell P. Tapasin and ERp57 form a stable disulfide-linked dimer within the MHC class I peptide-loading complex. EMBO J 2005: 24: 3613-23.
27. Kienast A, Preuss M, Winkler M, Dick TP. Redox regulation of peptide receptivity of major histocompatibility complex class I molecules by ERp57 and tapasin. Nat Immunol 2007: 8: 864-72.
28. Rufer E, Leonhardt RM, Knittler MR. Molecular architecture of the TAP-associated MHC class I peptide-loading complex. J Immunol 2007: 179: 5717-27.
29. Hermann C, Strittmatter LM, Deane JE, Boyle LH. The binding of TAPBPR and Tapasin to MHC class I is mutually exclusive. J Immunol 2013: 191: 5743-50.
30. Ortmann B, Copeman J, Lehner PJ et al. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 1997: 277: 1306-9.
31. Petersen JL, Hickman-Miller HD, McIlhaney MM et al. A charged amino acid residue in the transmembrane/cytoplasmic region of tapasin influences MHC class I assembly and maturation. J Immunol 2005: 174: 962-9.
32. Lehner PJ, Surman MJ, Cresswell P. Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line .220. Immunity 1998: 8: 221-31.
33. Dick TP, Bangia N, Peaper DR, Cresswell P. Disulfide bond isomerization and the assembly of MHC class I-peptide complexes. Immunity 2002: 16: 87-98.
34. Peaper DR, Cresswell P. The redox activity of ERp57 is not essential for its functions in MHC class I peptide loading. Proc Natl Acad Sci U S A 2008: 105: 10477-82.
35. Wearsch PA, Jakob CA, Vallin A, Dwek RA, Rudd PM, Cresswell P. Major histocompatibility complex class I molecules expressed with monoglucosylated N-linked glycans bind calreticulin independently of their assembly status. J Biol Chem 2004: 279: 25112-21.
36. Wearsch PA, Peaper DR, Cresswell P. Essential glycan-dependent interactions optimize MHC class I peptide loading. Proc Natl Acad Sci U S A 2011: 108: 4950-5.
37. Gao B, Adhikari R, Howarth M et al. Assembly and antigen-presenting function of MHC class I molecules in cells lacking the ER chaperone calreticulin. Immunity 2002: 16: 99-109.
38. Garbi N, Tan P, Diehl AD et al. Impaired immune responses and altered peptide repertoire in tapasin-deficient mice. Nat Immunol 2000: 1: 234-8.
39. Grandea AG 3rd, Golovina TN, Hamilton SE et al. Impaired assembly yet normal trafficking of MHC class I molecules in Tapasin mutant mice. Immunity 2000: 13: 213-22.
40. Williams AP, Peh CA, Purcell AW, McCluskey J, Elliott T. Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity 2002: 16: 509-20.
41. Howarth M, Williams A, Tolstrup AB, Elliott T. Tapasin enhances MHC class I peptide presentation according to peptide half-life. Proc Natl Acad Sci U S A 2004: 101: 11737-42.
42. Purcell AW, Gorman JJ, Garcia-Peydro M et al. Quantitative and qualitative influences of tapasin on the class I peptide repertoire. J Immunol 2001: 166: 1016-27.
43. Brocke P, Garbi N, Momburg F, Hammerling GJ. HLA-DM, HLA-DO and tapasin: functional similarities and differences. Curr Opin Immunol 2002: 14: 22-9.
44. Neisig A, Wubbolts R, Zang X, Melief C, Neefjes J. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J Immunol 1996: 156: 3196-206.
45. Turnquist HR, Thomas HJ, Prilliman KR, Lutz CT, Hildebrand WH, Solheim JC. HLA-B polymorphism affects interactions with multiple endoplasmic reticulum proteins. Eur J Immunol 2000: 30: 3021-8.
46. Turnquist HR, Schenk EL, McIlhaney MM, Hickman HD, Hildebrand WH, Solheim JC. Disparate binding of chaperone proteins by HLA-A subtypes. Immunogenetics 2002: 53: 830-4.
47. Lewis JW, Sewell A, Price D, Elliott T. HLA-A*0201 presents TAP-dependent peptide epitopes to cytotoxic T lymphocytes in the absence of tapasin. Eur J Immunol 1998: 28: 3214-20.
48. Greenwood R, Shimizu Y, Sekhon GS, DeMars R. Novel allele-specific, post-translational reduction in HLA class I surface expression in a mutant human B cell line. J Immunol 1994: 153: 5525-36.
49. Grandea AG 3rd, Androlewicz MJ, Athwal RS, Geraghty DE, Spies T. Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science 1995: 270: 105-8.
50. Peh CA, Burrows SR, Barnden M et al. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity 1998: 8: 531-42.
51. Rizvi SM, Salam N, Geng J et al. Distinct assembly profiles of HLA-B molecules. J Immunol 2014: 192: 4967-76.
52. Zernich D, Purcell AW, Macdonald WA et al. Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion. J Exp Med 2004: 200: 13-24.
53. Park B, Lee S, Kim E, Ahn K. A single polymorphic residue within the peptide-binding cleft of MHC class I molecules determines spectrum of tapasin dependence. J Immunol 2003: 170: 961-8.
54. Elliott T, Williams A. The optimization of peptide cargo bound to MHC class I molecules by the peptide-loading complex. Immunol Rev 2005: 207: 89-99.
55. Garstka MA, Fritzsche S, Lenart I et al. Tapasin dependence of major histocompatibility complex class I molecules correlates with their conformational flexibility. FASEB J 2011: 25: 3989-98.
56. Dalchau N, Phillips A, Goldstein LD et al. A peptide filtering relation quantifies MHC class I peptide optimization. PLoS Comput Biol 2011: 7: e1002144.
57. Dong G, Wearsch PA, Peaper DR, Cresswell P, Reinisch KM. Insights into MHC class I peptide loading from the structure of the tapasin-ERp57 thiol oxidoreductase heterodimer. Immunity 2009: 30: 21-32.
58. Chen M, Bouvier M. Analysis of interactions in a tapasin/class I complex provides a mechanism for peptide selection. EMBO J 2007: 26: 1681-90.
59. Suh WK, Mitchell EK, Yang Y, Peterson PA, Waneck GL, Williams DB. MHC class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extracellular domains. J Exp Med 1996: 184: 337-48.
60. Marguet D, Spiliotis ET, Pentcheva T, Lebowitz M, Schneck J, Edidin M. Lateral diffusion of GFP-tagged H2Ld molecules and of GFP-TAP1 reports on the assembly and retention of these molecules in the endoplasmic reticulum. Immunity 1999: 11: 231-40.
61. Spiliotis ET, Manley H, Osorio M, Zuniga MC, Edidin M. Selective export of MHC class I molecules from the ER after their dissociation from TAP. Immunity 2000: 13: 841-51.
62. Zhang W, Wearsch PA, Zhu Y, Leonhardt RM, Cresswell P. A role for UDP-glucose glycoprotein glucosyltransferase in expression and quality control of MHC class I molecules. Proc Natl Acad Sci U S A 2011: 108: 4956-61.
63. D'Alessio C, Caramelo JJ, Parodi AJ. UDP-GlC:glycoprotein glucosyltransferase-glucosidase II, the ying-yang of the ER quality control. Semin Cell Dev Biol 2010: 21: 491-9.
64. Kunte A, Zhang W, Paduraru C et al. Endoplasmic reticulum glycoprotein quality control regulates CD1d assembly and CD1d-mediated antigen presentation. J Biol Chem 2013: 288: 16391-402.
65. Boyle LH, Gillingham AK, Munro S, Trowsdale J. Selective export of HLA-F by its cytoplasmic tail. J Immunol 2006: 176: 6464-72.
66. Garstka M, Borchert B, Al-Balushi M et al. Peptide-receptive major histocompatibility complex class I molecules cycle between endoplasmic reticulum and cis-Golgi in wild-type lymphocytes. J Biol Chem 2007: 282: 30680-90.
67. Cho S, Ryoo J, Jun Y, Ahn K. Receptor-mediated ER export of human MHC class I molecules is regulated by the C-terminal single amino acid. Traffic 2011: 12: 42-55.
68. Paquet ME, Cohen-Doyle M, Shore GC, Williams DB. Bap29/31 influences the intracellular traffic of MHC class I molecules. J Immunol 2004: 172: 7548-55.
69. Ladasky JJ, Boyle S, Seth M et al. Bap31 enhances the endoplasmic reticulum export and quality control of human class I MHC molecules. J Immunol 2006: 177: 6172-81.
70. Abe F, Van Prooyen N, Ladasky JJ, Edidin M. Interaction of Bap31 and MHC class I molecules and their traffic out of the endoplasmic reticulum. J Immunol 2009: 182: 4776-83.
71. Park B, Lee S, Kim E, Chang S, Jin M, Ahn K. The truncated cytoplasmic tail of HLA-G serves a quality-control function in post-ER compartments. Immunity 2001: 15: 213-24.
72. van Hall T, Wolpert EZ, van Veelen P et al. Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. Nat Med 2006: 12: 417-24.
73. Lampen MH, Hassan C, Sluijter M et al. Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2. Mol Immunol 2013: 53: 126-31.
74. Oliveira CC, van Hall T. Importance of TAP-independent processing pathways. Mol Immunol 2013: 55: 113-6.
75. Del Val M, Lazaro S, Ramos M, Anton LC. Are membrane proteins favored over cytosolic proteins in TAP-independent processing pathways? Mol Immunol 2013: 55: 117-9.
76. Wei ML, Cresswell P. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 1992: 356: 443-6.
77. Sugita M, Brenner MB. Association of the invariant chain with major histocompatibility complex class I molecules directs trafficking to endocytic compartments. J Biol Chem 1995: 270: 1443-8.
78. Vigna JL, Smith KD, Lutz CT. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove. J Immunol 1996: 157: 4503-10.
79. Bevan MJ. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 1976: 143: 1283-8.
80. Joffre OP, Segura E, Savina A, Amigorena S. Cross-presentation by dendritic cells. Nat Rev Immunol 2012: 12: 557-69.
81. Kleijmeer MJ, Escola JM, UytdeHaag FG et al. Antigen loading of MHC class I molecules in the endocytic tract. Traffic 2001: 2: 124-37.
82. Basha G, Omilusik K, Chavez-Steenbock A et al. A CD74-dependent MHC class I endolysosomal cross-presentation pathway. Nat Immunol 2012: 13: 237-45.
83. Du Pasquier L. The phylogenetic origin of antigen-specific receptors. Curr Top Microbiol Immunol 2000: 248: 160-85.
84. Teng MS, Stephens R, Du Pasquier L, Freeman T, Lindquist JA, Trowsdale J. A human TAPBP (TAPASIN)-related gene, TAPBP-R. Eur J Immunol 2002: 32: 1059-68.
85. Landis ED, Palti Y, Dekoning J, Drew R, Phillips RB, Hansen JD. Identification and regulatory analysis of rainbow trout tapasin and tapasin-related genes. Immunogenetics 2006: 58: 56-69.
86. Boyle LH, Hermann C, Boname JM et al. Tapasin-related protein TAPBPR is an additional component of the MHC class I presentation pathway. Proc Natl Acad Sci U S A 2013: 110: 3465-70.
87. Paulsson KM, Jevon M, Wang JW, Li S, Wang P. The double lysine motif of tapasin is a retrieval signal for retention of unstable MHC class I molecules in the endoplasmic reticulum. J Immunol 2006: 176: 7482-8.
88. Korfali N, Wilkie GS, Swanson SK et al. The leukocyte nuclear envelope proteome varies with cell activation and contains novel transmembrane proteins that affect genome architecture. Mol Cell Proteomics 2010: 9: 2571-85.
89. Denzin LK, Sant'Angelo DB, Hammond C, Surman MJ, Cresswell P. Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 1997: 278: 106-9.
90. van Ham SM, Tjin EP, Lillemeier BF et al. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr Biol 1997: 7: 950-7.
91. Denzin LK, Fallas JL, Prendes M, Yi W. Right place, right time, right peptide: DO keeps DM focused. Immunol Rev 2005: 207: 279-92.
92. Roche PA, Cresswell P. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 1990: 345: 615-8.
93. Riberdy JM, Newcomb JR, Surman MJ, Barbosa JA, Cresswell P. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 1992: 360: 474-7.
94. Bakke O, Dobberstein B. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 1990: 63: 707-16.
95. Lotteau V, Teyton L, Peleraux A et al. Intracellular transport of class II MHC molecules directed by invariant chain. Nature 1990: 348: 600-5.
96. Romagnoli P, Layet C, Yewdell J, Bakke O, Germain RN. Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments. J Exp Med 1993: 177: 583-96.
97. Roche PA, Cresswell P. Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc Natl Acad Sci U S A 1991: 88: 3150-4.
98. Maric MA, Taylor MD, Blum JS. Endosomal aspartic proteinases are required for invariant-chain processing. Proc Natl Acad Sci U S A 1994: 91: 2171-5.
99. Kozik P, Francis RW, Seaman MN, Robinson MS. A screen for endocytic motifs. Traffic 2010: 11: 843-55.
100. Porter KM, Hermann C, Traherne JA, Boyle LH. TAPBPR isoforms exhibit altered association with MHC class I. Immunology 2014: 142: 289-99.
101. Chen QR, Hu Y, Yan C, Buetow K, Meerzaman D. Systematic genetic analysis identifies Cis-eQTL target genes associated with glioblastoma patient survival. PLoS One 2014: 9: e105393.
102. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet 1973: 1: 904-7.
103. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973: 288: 704-6.
104. Wellcome Trust Case Control Consortium, Australo-Anglo-American Spondylitis Consortium, Burton PR et al. Association scan of 14, 500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007: 39: 1329-37.
105. Evans DM, Spencer CC, Pointon JJ et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011: 43: 761-7.
106. Reeves E, Edwards CJ, Elliott T, James E. Naturally occurring ERAP1 haplotypes encode functionally distinct alleles with fine substrate specificity. J Immunol 2013: 191: 35-43.
107. Goulder PJ, Walker BD. HIV and HLA class I: an evolving relationship. Immunity 2012: 37: 426-40.